Literature DB >> 17972946

Third party mesenchymal stromal cell infusions fail to induce tissue repair despite successful control of severe grade IV acute graft-versus-host disease in a child with juvenile myelo-monocytic leukemia.

L Ball, R Bredius, A Lankester, J Schweizer, M van den Heuvel-Eibrink, H Escher, W Fibbe, M Egeler.   

Abstract

Entities:  

Mesh：

Year:  2007        PMID： 17972946     DOI： 10.1038/sj.leu.2405013

Source DB:  PubMed          Journal:  Leukemia        ISSN： 0887-6924            Impact factor:   11.528


× No keyword cloud information.
  11 in total

1.  Inflammation and cancer.

Authors:  Noemí Eiró; Francisco J Vizoso
Journal:  World J Gastrointest Surg       Date:  2012-03-27

2.  CD271 antigen defines a subset of multipotent stromal cells with immunosuppressive and lymphohematopoietic engraftment-promoting properties.

Authors:  Selim Kuçi; Zyrafete Kuçi; Hermann Kreyenberg; Erika Deak; Kathrin Pütsch; Sabine Huenecke; Chandrasekhar Amara; Stefanie Koller; Eva Rettinger; Manuel Grez; Ulrike Koehl; Hatixhe Latifi-Pupovci; Reinhard Henschler; Torsten Tonn; Dorothee von Laer; Thomas Klingebiel; Peter Bader
Journal:  Haematologica       Date:  2010-02-23       Impact factor: 9.941

3.  Combination stem cell therapy for heart failure.

Authors:  Thomas E Ichim; Fabio Solano; Fabian Lara; Jorge Paz Rodriguez; Octav Cristea; Boris Minev; Famela Ramos; Erik J Woods; Michael P Murphy; Doru T Alexandrescu; Amit N Patel; Neil H Riordan
Journal:  Int Arch Med       Date:  2010-04-14

4.  Human mesenchymal stromal cells attenuate graft-versus-host disease and maintain graft-versus-leukemia activity following experimental allogeneic bone marrow transplantation.

Authors:  Jeffery J Auletta; Saada K Eid; Patiwet Wuttisarnwattana; Ines Silva; Leland Metheny; Matthew D Keller; Rocio Guardia-Wolff; Chen Liu; Fangjing Wang; Theodore Bowen; Zhenghong Lee; Luis A Solchaga; Sudipto Ganguly; Megan Tyler; David L Wilson; Kenneth R Cooke
Journal:  Stem Cells       Date:  2015-02       Impact factor: 6.277

5.  Mesenchymal stromal cells for steroid-refractory acute graft-versus-host disease: a report of two cases.

Authors:  Joo Han Lim; Moon Hee Lee; Hyeon Gyu Yi; Chul Soo Kim; Jun Hyung Kim; Sun U Song
Journal:  Int J Hematol       Date:  2010-06-01       Impact factor: 2.490

Review 6.  Extracorporeal photopheresis versus standard treatment for acute graft-versus-host disease after haematopoietic stem cell transplantation in children and adolescents.

Authors:  Kathrin Buder; Matthias Zirngibl; Sascha Bapistella; Joerg J Meerpohl; Brigitte Strahm; Dirk Bassler; Marcus Weitz
Journal:  Cochrane Database Syst Rev       Date:  2022-09-27

Review 7.  Regenerative stromal cell therapy in allogeneic hematopoietic stem cell transplantation: current impact and future directions.

Authors:  Jeffery J Auletta; Kenneth R Cooke; Luis A Solchaga; Robert J Deans; Wouter van't Hof
Journal:  Biol Blood Marrow Transplant       Date:  2009-12-16       Impact factor: 5.742

Review 8.  Mesenchymal stem cells in tumor development: emerging roles and concepts.

Authors:  Benjamin G Cuiffo; Antoine E Karnoub
Journal:  Cell Adh Migr       Date:  2012-05-01       Impact factor: 3.405

Review 9.  Extracorporeal photopheresis versus standard treatment for acute graft-versus-host disease after haematopoietic stem cell transplantation in paediatric patients.

Authors:  Marcus Weitz; Brigitte Strahm; Joerg J Meerpohl; Maria Schmidt; Dirk Bassler
Journal:  Cochrane Database Syst Rev       Date:  2015-12-15

10.  Feasibility investigation of allogeneic endometrial regenerative cells.

Authors:  Zhaohui Zhong; Amit N Patel; Thomas E Ichim; Neil H Riordan; Hao Wang; Wei-Ping Min; Erik J Woods; Michael Reid; Eduardo Mansilla; Gustavo H Marin; Hugo Drago; Michael P Murphy; Boris Minev
Journal:  J Transl Med       Date:  2009-02-20       Impact factor: 5.531
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.